Biden awards $24M to develop mRNA tech targeting cancer, other diseases

The Biden ad­min­is­tra­tion’s new bio­med­ical re­search agency is launch­ing a $24.8 mil­lion project to de­vel­op mR­NA plat­forms with the goal of us­ing the tech­nol­o­gy to fight can­cer and oth­er life threat­en­ing dis­eases.

The Ad­vanced Re­search Project Agency for Health (ARPA-H), which was es­tab­lished last year, is part­ner­ing with Emory Uni­ver­si­ty in At­lanta to spear­head a three-year project dubbed “CURE­IT,” which stands for Cur­ing the Un­cur­able via RNA-En­cod­ed Im­muno­gene Tun­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.